Sisu Partners acted as financial advisor in Nexstim Plc’s €3.6 million rights issue in May 2019. Nexstim (NXTMH:HEX, NXTMS:STO) is a targeted neuromodulation company developing and marketing pioneering, navigated, personalized, non-invasive brain stimulation systems for the treatment of Major Depressive Disorder (MDD).